Craft

Advanced
Akelos

Akelos

Total Funding

$2.1 M

Akelos Summary

Company Summary

Overview
Akelos is a research-based biopharmaceutical clinical company. It develops non-narcotic drugs for the treatment of neuropathic pain. The company aims to offer alternatives to opioid therapies.
Type
Private
Status
Active
Founded
2018
HQ
New York, NY, US | view all locations
Website
http://www.akelosinc.com/
Cybersecurity rating
Sectors

Table of Contents

Key People

  • Steven R. Fox

    Steven R. Fox, Founder

    • Peter Hutt

      Peter Hutt, FDA Counsel

      • Roger Frechette

        Roger Frechette, Director of Operations & Business Development

        • Peter Goldstein

          Peter Goldstein, Scientific Founder

          LocationsView all

          1 location detected

          • New York, NY HQ

            United States

            40 Park Ave

          Competitors and Similar Companies

          Compare competitors

          Footer menu

          Product

          Solutions

          Resources

          Company

          © Craft.co 2026
          Share price data provided by IEX